Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,942,712
-$864,053 QoQ
Shares Held
19,642
-26.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,321
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hodges Capital Management Inc. holds $30,757,198 across 7 Drug Manufacturers - General names. ABBV ranks #3 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,780 | $12,929,856 | |
| 2 | JNJ |
Johnson & Johnson
|
23,026 | $5,847,913 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
19,642 | $4,942,712 | |
| 4 | AMGN |
Amgen Inc
|
7,363 | $2,666,289 | |
| 5 | NVO |
Novo Nordisk A S
|
51,300 | $2,459,322 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
9,315 | $1,176,857 | |
| 7 | MRK |
Merck & Co., Inc.
|
5,714 | $734,249 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,942,712 | 19,642 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $5,806,765 | 26,699 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $7,276,721 | 31,847 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $7,485,919 | 32,331 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $6,047,128 | 32,578 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $7,104,194 | 33,907 | Shares | Sole | 2025-06-02 | |
| 2024-12-31 | $7,283,745 | 40,989 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $6,991,186 | 35,402 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $6,106,455 | 35,602 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $5,700,822 | 31,306 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $6,206,238 | 40,048 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,622,456 | 24,302 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,679 | 34,707 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $6,570,346 | 41,227 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,799,417 | 42,073 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $4,808,073 | 35,825 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $6,760,176 | 44,138 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $7,834,452 | 48,328 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,886,102 | 58,243 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $6,333,479 | 58,714 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $5,916,753 | 52,528 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $6,554,560 | 60,567 | Shares | Sole | 2021-04-07 | |
| 2020-12-31 | $6,520,184 | 60,851 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $5,514,053 | 62,953 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $5,601,758 | 57,056 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $4,167,745 | 54,702 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||